CASSAVA SCIENCES INC - Common Stock (SAVA) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2019 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
SAVA on Nasdaq
Shares outstanding
48,331,225
Price per share
$1.98
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
13,778,326
Total reported value
$40,074,441
% of total 13F portfolios
0%
Share change
+1,605,412
Value change
+$5,019,405
Number of holders
101
Price from insider filings
$1.98
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CASSAVA SCIENCES INC - Common Stock (SAVA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nachtrab Matthew 4.7% $3,560,189 2,267,636 Nachtrab Matthew 16 Aug 2024
VANGUARD GROUP INC 4.5% $3,927,830 2,170,072 The Vanguard Group 30 Jun 2025
BlackRock, Inc. 3.2% $2,797,129 1,545,375 BlackRock, Inc. 30 Jun 2025

As of 30 Sep 2025, 101 institutional investors reported holding 13,778,326 shares of CASSAVA SCIENCES INC - Common Stock (SAVA). This represents 29% of the company’s total 48,331,225 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CASSAVA SCIENCES INC - Common Stock (SAVA) together control 27% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 4.7% 2,289,523 +5.5% 0% $6,662,512
MARSHALL WACE, LLP 4.3% 2,061,286 +2774% 0.01% $5,998,343
BlackRock, Inc. 2.9% 1,409,156 -8.8% 0% $4,100,644
TWO SIGMA ADVISERS, LP 2% 961,500 -2.2% 0.01% $2,797,965
JPMORGAN CHASE & CO 1.2% 565,439 -25% 0% $1,645,428
TWO SIGMA INVESTMENTS, LP 1.2% 564,998 +7.3% 0% $1,644,144
GEODE CAPITAL MANAGEMENT, LLC 1.1% 537,901 +2.9% 0% $1,565,933
GOLDMAN SACHS GROUP INC 0.98% 472,860 -23% 0% $1,376,023
GMT CAPITAL CORP 0.93% 450,100 0% 0.06% $1,309,791
683 Capital Management, LLC 0.88% 425,000 0.11% $1,236,750
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.79% 382,018 -14% 0% $1,111,672
MORGAN STANLEY 0.72% 350,059 -22% 0% $1,018,672
MILLENNIUM MANAGEMENT LLC 0.66% 318,886 -33% 0% $927,958
JACOBS LEVY EQUITY MANAGEMENT, INC 0.46% 224,658 0% $653,755
STATE STREET CORP 0.44% 213,037 -2% 0% $619,938
Susquehanna Portfolio Strategies, LLC 0.43% 206,835 +55% 0.01% $601,890
GROUP ONE TRADING LLC 0.42% 201,616 -6.8% 0.02% $586,703
JANE STREET GROUP, LLC 0.4% 195,571 -42% 0% $569,111
UBS Group AG 0.39% 188,993 -0.57% 0% $549,970
SIMPLEX TRADING, LLC 0.33% 161,678 +837% 0.01% $470,000
Cubist Systematic Strategies, LLC 0.31% 150,088 -52% 0.01% $436,756
Voleon Capital Management LP 0.29% 142,385 0.01% $414,340
NORTHERN TRUST CORP 0.27% 131,170 +29% 0% $381,705
Graham Capital Management, L.P. 0.24% 117,927 0.01% $343,168
XTX Topco Ltd 0.18% 88,563 +91% 0.01% $257,718

Institutional Holders of CASSAVA SCIENCES INC - Common Stock (SAVA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 54,038 $106,995 -$91,483 $1.98 6
2025 Q3 13,778,326 $40,074,441 +$5,019,405 $2.91 101
2025 Q2 12,246,863 $22,166,624 -$6,209,960 $1.81 96
2025 Q1 15,768,881 $23,653,533 -$3,650,996 $1.50 114
2024 Q4 17,411,806 $41,096,950 -$26,811,358 $2.36 135
2024 Q3 14,006,298 $412,343,524 +$21,408,686 $29.43 159
2024 Q2 13,297,542 $164,180,761 +$20,340,671 $12.35 140
2024 Q1 11,593,879 $235,338,414 -$49,008,344 $20.29 141
2023 Q4 13,929,974 $313,474,831 +$20,318,834 $22.51 150
2023 Q3 12,909,705 $214,797,641 +$17,325,070 $16.64 136
2023 Q2 11,697,131 $286,735,353 -$6,324,947 $24.52 150
2023 Q1 11,914,630 $287,373,528 +$15,058,161 $24.12 140
2022 Q4 11,254,249 $332,457,243 +$2,217,261 $29.54 146
2022 Q3 10,511,058 $439,522,416 +$28,422,554 $41.82 164
2022 Q2 9,860,019 $277,264,167 -$22,312,348 $28.12 136
2022 Q1 10,487,576 $389,768,314 -$39,764,775 $37.14 147
2021 Q4 11,534,283 $504,052,860 -$49,487,683 $43.70 160
2021 Q3 12,113,852 $751,991,955 +$67,636,793 $62.08 169
2021 Q2 10,434,065 $891,498,117 +$48,315,268 $85.44 163
2021 Q1 10,158,803 $456,594,941 +$91,884,258 $44.95 116
2020 Q4 9,404,804 $64,135,775 +$15,501,397 $6.82 70
2020 Q3 6,699,572 $77,113,513 +$9,133,318 $11.51 63
2020 Q2 5,994,033 $18,463,673 -$2,167,955 $3.08 47
2020 Q1 6,007,016 $24,760,000 +$5,851,160 $4.11 38
2019 Q4 4,360,623 $22,674,000 +$6,170,969 $5.20 27
2019 Q3 1,823,694 $2,188,000 -$1,850,994 $1.20 16
2019 Q2 3,351,011 $4,055,000 +$2,993 $1.21 20
2019 Q1 3,342,185 $4,312,000 +$4,312,000 $1.29 22